New drug aims to slow kidney damage in diabetes and rare diseases
Disease control
Recruiting now
This study tests an experimental drug called WAL0921 in 96 adults with kidney diseases that cause protein in the urine, including diabetic nephropathy and several rare conditions. Participants receive either the drug or a placebo as an IV infusion every two weeks for 14 weeks, th…
Phase: PHASE2 • Sponsor: Walden Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC